Jiana Chen

Jiana Chen

Auto-generated profile, based on publicly available information

Jiana Chen

Department of Pharmacy, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Maternity and Child Health Hospital, Fujian Medical University, Fuzhou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2023 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
JCJiana Chen
Jiana Chen
ZZZhiwei Zeng
Zhiwei Zeng
ZFZongwei Fang
Zongwei Fang
FMFuxin Ma
Fuxin Ma
MLMeina Lv
Meina Lv
JZJinhua Zhang
Jinhua Zhang
Background: Thrombolysis-related intracranial hemorrhage has a high mortality rate, and many factors can cause intracranial hemorrhage. Until now, systematic reviews and assessments of the certainty of the evidence have not been updated.Aim: We conducted a systematic review to identify risk factors for thrombolysis-related intracranial hemorrhage.Method: The protocol for this systematic review was prospectively registered with PROSPERO (CRD42022316160). All English studies that met the inclusion criteria published before January 2022 were obtained from PubMed, EMBASE, Web of Science, and Cochrane Library. Two researchers independently screened articles, extracted data, and evaluated the quality and evidence of the included studies. Risk factors for intracranial hemorrhage were used as the outcome index of this review. Random or fixed-effect models were used in statistical methods.Results: Of 6083 citations, we included 105 studies in our analysis. For intracranial hemorrhage, moderate-certainty evidence showed a probable association with age, National Institutes of Health stroke scale, leukoaraiosis, hypertension, atrial fibrillation, diabetes, total cholesterol, proteinuria, fibrinogen levels, creatinine, homocysteine, early infarct signs, antiplatelet therapy and anticoagulant therapy; In addition, we found low-certainty evidence that there may be little to no association between risk of intracranial hemorrhage and weight, sex, platelet count, uric acid, albumin and white matter hyperintensity. Leukoaraiosis, cardiovascular disease, total cholesterol, white blood cell count, proteinuria, fibrinogen levels, creatinine, homocysteine and early CT hypodensities are not included in most intracranial hemorrhage risk assessment models.Conclusion: This study informs risk prediction for thrombolysis-related intracranial hemorrhage, it also informs guidelines for intracranial hemorrhage prevention and future research.

20 January 2023 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
ZZZhiwei Zeng
Zhiwei Zeng
JCJiana Chen
Jiana Chen
JQJiafen Qian
Jiafen Qian
FMFuxin Ma
Fuxin Ma
MLMeina Lv
Meina Lv
JZJinhua Zhang
Jinhua Zhang


18 August 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
ZZZhiwei Zeng
Zhiwei Zeng
JCJiana Chen
Jiana Chen
MCMingrong Chen
Mingrong Chen
FMFuxin Ma
Fuxin Ma
MLMeina Lv
Meina Lv
JZJinhua Zhang
Jinhua Zhang

18 June 2024 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
PDF file
WXWenlin Xu
Wenlin Xu
TWTingting Wu
Tingting Wu
JCJiana Chen
Jiana Chen
MLMeina Lv
Meina Lv
NWNa Wang
Na Wang
JZJinhua Zhang
Jinhua Zhang
Aims: Many people diagnosed with atrial fibrillation (AF) may lack awareness of AF and anticoagulants. The purpose of this study is to investigate the effects of intensive, targeted education by pharmacists on anticoagulant patients with AF. Methods and results: Three hundred seventy-six AF patients were randomly assigned to receive standard care or pharmacist education. Follow-up is scheduled after 1, 3, 6, and 12 months. Pharmacists provided intensive education on knowledge deficits revealed by the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) during each visit. Patients also completed two questionnaires to assess their medication adherence and satisfaction. Clinical outcomes were recorded during follow-up. Three hundred sixty-one patients completed follow-up. Baseline scores on the JAKQ were similar in the education group (median: 31.3%) and the standard care group (median: 31.3%) (P = 0.911). Over time, the knowledge score of the education group increased significantly (1 month: 68.8%, 3 months: 81.3%; P < 0.001), while there was no significant improvement in the standard care group (1 month: 37.5%, 3 months: 37.5%; P = 0.314). Adherence scores improved significantly over time in the education group (P < 0.001) but not in the standard care group (P = 0.101). Compared with standard care, pharmacist education was associated with a significantly lower risk of bleeding (P = 0.034). Conclusion: Given the knowledge deficiency of AF patients in China, standardized patient education should be a part of their daily care. Pharmacist-led education intervention can significantly improve the disease-related knowledge, medication adherence, and drug treatment satisfaction of AF patients while significantly reducing the risk of bleeding. Registration: ChiCTR1900024455.

17 April 2024 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
FMFuxin Ma
Fuxin Ma
ZZZhiwei Zeng
Zhiwei Zeng
JCJiana Chen
Jiana Chen
JZJinhua Zhang
Jinhua Zhang